Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05521230
Other study ID # 2021_CE112
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date September 1, 2021
Est. completion date April 30, 2022

Study information

Verified date August 2022
Source University of Santiago de Compostela
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this project was to investigate the short-term in situ anti-plaque effect of cymenol, using the Dentius Deep Plaque software


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 30, 2022
Est. primary completion date March 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 45 Years
Eligibility Inclusion criteria were as follows: - Systemically healthy volunteers - Age between 20-45 years - Presence of minimum of 24 permanent teeth - No evidence of gingivitis or periodontitis (CPITN= 0) - No presence of untreated caries at the start of the study. Exclusion criteria were as follows: - Smoker or ex-smoker - Presence of dentures or orthodontic appliances - Antibiotic treatment in the last 3 months or routine use of oral antiseptics

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Placebo Mouthwash
Application of mouthwashes
Cymenol mouthwash
Application of mouthwashes

Locations

Country Name City State
Spain University of Santiago de Compostela Santiago de Compostela A Coruña

Sponsors (2)

Lead Sponsor Collaborator
University of Santiago de Compostela Lacer, S.A.

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the plaque area: baseline vs 4 days Change in the percentage of the tooth surface with dental plaque:baseline vs 4 days Baseline, 4 days
Primary Change in the plaque area: baseline vs 8 days Change in the percentage of the tooth surface with dental plaque: baseline vs 8 days Baseline, 8 days
Primary Change in the plaque area: 4 days vs 8 days Change in the percentage of the tooth surface with dental plaque: 4 days vs 8 days 4 days, 8 days
Primary Change in the growth rate of dental plaque area: baseline vs 4 days Change in the growth rate of dental plaque area (percentage area/hour): baseline vs 4 days Baseline, 4 days
Primary Change in the growth rate of dental plaque area: baseline vs 8 days Change in the growth rate of dental plaque area (percentage area/hour): baseline vs 8 days Baseline, 8 days
Primary Change in the growth rate of dental plaque area: 4 days vs 8 days Change in the growth rate of dental plaque area (percentage area/hour): 4 days vs 8 days 4 days vs 8 days
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1